M. Moezi

Physical activity during COVID-19 pandemic in the Iranian population: A brief report

Hamid Amini, Amin Isanejad, N. Chamani et al. · Heliyon · 2020 · 62 citations · Full text

A phase I trial of pan-Bcl-2 antagonist obatoclax administered as a 3-h or a 24-h infusion in combination with carboplatin and etoposide in patients with extensive-stage small cell lung cancer

Alberto Chiappori, Marshall T. Schreeder, M. Moezi et al. · British Journal of Cancer · 2012 · 49 citations · Full text

Hematological Malignancy, Medicine, Pharmacology +15

A randomized phase II study of carboplatin (C) and etoposide (E) with or without pan-BCL-2 antagonist obatoclax (Ob) in extensive-stage small cell lung cancer (ES-SCLC).

Corey J. Langer, István Albert, P Kovács et al. · Journal of Clinical Oncology · 2011 · 19 citations

Ob Arm, Pharmacotherapy, Treatment Verification +20

The prevalence of depression among the elderly population of Shaystegan and Jahandidegan nursing homes in Shahrekord

Mahmoud Mobasheri, M. Moezi · 2010 · 12 citations

Nursing, Psychiatry, Geriatrics +7

A phase Ib trial of Bcl-2 inhibitor obatoclax in combination with carboplatin and etoposide for previously untreated patients with extensive-stage small cell lung cancer (ES-SCLC)

Alberto Chiappori, Marshall T. Schreeder, M. Moezi et al. · Journal of Clinical Oncology · 2009 · 11 citations

Phase Ib Trial, Pharmacotherapy, Pharmacodynamic Modeling +23